๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

8 EARLY PREDICTION OF SUSTAINED RESPONSE TO PEGINTERFERON ALFA-2A IN HBEAG-NEGATIVE PATIENTS: THE ROLE OF ON-TREATMENT HBSAG AND HBV DNA LEVELS

โœ Scribed by V. Rijckborst; B.E. Hansen; Y. Cakaloglu; P. Ferenci; F. Tabak; M. Akdogan; K. Simon; U.S. Akarca; R. Flisiak; E. Verhey; A.J. van Vuuren; C.A.B. Boucher; M.J. ter Borg; H.L.A. Janssen


Book ID
117378096
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
106 KB
Volume
52
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Early on-treatment prediction of respons
โœ Vincent Rijckborst; Bettina E. Hansen; Yilmaz Cakaloglu; Peter Ferenci; Fehmi Ta ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 189 KB ๐Ÿ‘ 2 views

Ferenci is a consultant for, advises, is on the speakers' bureau of, and received grants from Roche. Dr. Janssen is a consultant for and received grants from Roche, Bristol-Myers Squibb, Schering-Plough, Novartis, and Gilead. Dr. Flisiak received grants from Roche.